Biologic roles of gangliosides GM3 and GD3 in the attachment of human melanoma cells to extracellular matrix proteins

被引:19
|
作者
Nakano, J
Yasui, H
Lloyd, KO
Muto, M
机构
[1] Yamaguchi Univ, Sch Med, Dept Dermatol, Ube, Yamaguchi 7558505, Japan
[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
关键词
cell adhesion; collagen; fibronectin; laminin;
D O I
10.1038/sj.jidsp.5640204
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The biologic functions of gangliosides G(M3) and G(D3) in the attachment of human melanoma cells to extracellular matrix proteins (type I and TV collagens, fibronectin, and laminin) were investigated by using the G(D3)-deficient mutant clone (SK-MEL-28-N1) and the parent cell line SK-MEL28, SK-MEL-28-N1 (N1) (high G(M3) expression: G(M3), 97.3%; G(D3), 0%) Was selected by treating SK-MEG 28 (high G(D3) but low G(M3): G(M3), 6.5%, G(D3), 93.5%) with an anti-G(D3) monoclonal antibody (R24) and rabbit complement and subsequent subcloning of the surviving cells. The N1 clone showed significantly higher ability to adhere to type I and IV collagens and laminin than the parent clone SK-MEL-28, In the N1 clone, the expression of alpha 2 beta 1 and alpha 3 beta 1 integrin receptors was increased, whereas in SK-MEL28, their expression was very low or undetectable. The treatment with monoclonal antibodies directed specifically to G(D3) expressed on SK-MEL28 inhibited the cell attachment to type TV collagen (33% inhibition of control), fibronectin (59%), and laminin (71%). These findings suggest that gangliosides G(M3) (by influencing integrin receptor levels) and G(D3) (by interacting directly with matrix proteins) might play some functional roles in attachment to extracellular matrix proteins and thereby enhance the metastatic potency of melanoma cells.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 50 条
  • [31] Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides
    Rui Ma
    Atanas Koulov
    Christopher Moulton
    Manju Basu
    Sipra Banerjee
    Holly Goodson
    Subhash Basu
    Glycoconjugate Journal, 2003, 20 : 319 - 330
  • [32] Milk-derived GM3 and GD3 differentially inhibit dendritic cell maturation and effector functionalities
    Bronnum, H
    Seested, T
    Hellgren, LI
    Brix, S
    Frokiær, H
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 61 (06) : 551 - 557
  • [33] GT3 synthesis in the proximal Golgi occurs in a compartment different from those for GD3 and GM3 synthesis
    Fritz, VMR
    Maxzud, MK
    Maccioni, HJF
    JOURNAL OF NEUROCHEMISTRY, 1996, 67 (04) : 1393 - 1400
  • [34] Expression of the human CMP-NeuAc:GM3 α2,8-sialyltransferase (GD3 synthase) gene through the NF-κB activation in human melanoma SK-MEL-2 cells
    Kang, Nam-Young
    Kim, Cheorl-Ho
    Kim, Kyoung-Sook
    Ko, Jeong-Heon
    Lee, Jai-Heon
    Jeong, Yong-Kee
    Lee, Young-Choon
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2007, 1769 (11-12): : 622 - 630
  • [35] PURIFICATION TO HOMOGENEITY OF GD3 SYNTHASE AND PARTIAL-PURIFICATION OF GM3 SYNTHASE FROM RAT-BRAIN
    GU, XB
    GU, TJ
    YU, RK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (01) : 387 - 393
  • [36] GANGLIOSIDE GD3 SHEDDING BY CULTURED HUMAN-MALIGNANT MELANOMA-CELLS
    BERNHARD, H
    DIPPOLD, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 383 - 383
  • [37] Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma
    Saha, S
    Mohanty, KC
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (01): : 125 - 134
  • [38] INHIBITION BY GANGLIOSIDES GM3, GD3 AND GT1B OF SUBSTRATE PHOSPHORYLATION BY PROTEIN-KINASE-C IN BOVINE MAMMARY-GLAND AND ITS REVERSAL BY PHOSPHATIDYLSERINE
    KATOH, N
    LIFE SCIENCES, 1994, 56 (03) : 157 - 162
  • [39] 外源性GM3/GD3对人肝癌培养细胞蛋白激酶活性的影响
    何伟,刘银坤,张夏英,宋家
    生物化学杂志, 1995, (06) : 689 - 692
  • [40] MODULATION OF A GLYCOLIPID ANTIGEN, GD3, IN HUMAN-MALIGNANT MELANOMA
    GRANBERRY, ME
    LEONG, SPL
    HOUGHTON, AN
    CLINICAL RESEARCH, 1989, 37 (01): : A143 - A143